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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. The beneficial effects by peroxisome proliferator activated receptor 
γ (PPAR γ) on gastric injury induced by ischemia reperfusion have
been confirmed, however, the precise mechanism of its cyto 
protection is not elucidated thoroughly. The aim of the present
study was to determine the gastric localization of PPAR γ expres 
sion in the rat gastric mucosa, and to clarify the mechanism of its
cytoprotective properties. The gastric expression of PPAR γ was
confirmed by RT PCR and western blot, and localized on gastric
epithelial cells. The protective effect of PPAR γ ligands, pioglitazone
or 15 deoxy Δ12,14 prostaglandin J2, on gastric ischemia reperfusion
injury was reversed by the co administration with PPAR γ antago 
nist. The gastric expression of tumor necrosis factor α and cyto 
kine induced neutrophil chemoattractant 1 increased significantly
in rats treated ischemia reperfusion, and these increases were
significantly inhibited by treatment with pioglitazone. Among the
1,032 probes, 18 probes were up regulated at least 1.5 fold, 17 were
down regulated at least 1.5 fold by pioglitazone. The network
including calnexin, endoplasmic reticulum stress protein, heat shock
proteins, and proteasome genes was induced by pioglitazone
treatment. In conclusion, activation of gastric epithelial PPAR γ
receptor by its ligands may represent a novel therapeutic
approach for gastric inflammation via up regulation of heat shock
proteins and endoplasmic reticulum related proteins.
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Introduction The signaling of ischemia or ischemia-reperfusion (I-R) is a
major contributing condition leading to gastric mucosal
injury induced by stress,(1,2) non-steroidal anti-inflammatory drugs
(NSAIDs),(3) and Helicobacter pylori infection.(4) Gastric I-R
causes mucosal ulcerative lesions as well as acute inflammation
associated with neutrophil accumulation.(5–7) Previous studies have
demonstrated that the infiltration of neutrophils into gastric tissue
via neutrophil-endothelial cell interactions plays a critical role in
the pathogenesis of I-R-induced gastric injury, because neutro-
phils generate tissue damage factors such as reactive oxygen
species and proteases.(6,8) Neutrophil accumulation is a complex
phenomenon that also involves various adhesion molecules and
inflammatory mediators. Using a rat model of gastric I-R, we have
revealed that reactive oxygen species play a crucial role in the
pathogenesis of reperfusion-induced mucosal injury.(6,7) In addi-
tion to reactive oxygen species, a variety of cytokines, including
interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), and IL-1β,
are released from post-ischemic gastric tissue to modulate tissue
repair and adaptation. These cytokines are elaborated soon after
gastric ischemic injury and can acutely regulate gastric mucosal
survival or apoptosis and trigger additional cellular inflammatory
response.
The peroxisome proliferator-activated receptors (PPARs) are
members of the nuclear receptor supergene family that function
in ligand-activated transcription.(9,10) PPARs consist of at least
three isoforms, α, β, and γ, encoded by unique genes. Among
them, PPAR-γ is highly expressed in adipose tissue, colon, spleen,
adrenal gland, and macrophages. Previous studies have demon-
strated that the naturally occurring arachidonic acid metabolite,
15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), as well as thiazoli-
dinedione (TZD) and certain novel non-TZD insulin-sensitizing
agents, are ligands and agonist of this receptor. Although PPAR-γ
play a key role in adipose differentiation, lipid metabolism, and
glucose homeostasis, recent studies suggest that they might be
involved in the control of inflammation and especially in the
modulation of the expression of various cytokines in monocytes
and macrophages.(11–13)
Recently, our group and others reported that PPAR-γ plays
an anti-inflammatory role in gastric inflammation induced by
I-R,(14–18) aspirin,(19) and Helicobacter pylori infection(20) in rats.
In 2001, we firstly demonstrated that pioglitazone, a synthetic
TZD, markedly reduced gastric erosions induced by aspirin as
well as inhibited the enhanced expression of pro-inflammatory
cytokine TNF-α.(19) In addition, we have reported the gastric
cytoprotection by pioglitazone and 15d-PGJ2 against I-R injury,
associated with anti-inflammatory actions of these ligands.(14,18)
This beneficial effects by PPAR-γ ligands on I-R-induced gastric
injury have been also confirmed by several investigators, however,
the precise mechanism of the cytoprotection in vivo is not
elucidated thoroughly. In addition, Nakajima et al.(21) showed
that no expression of PPAR-γ could be detected by Western blot
analysis in the rat stomach.
On the basis of these observations, we determined the gastric
localization of PPAR-γ expression in the rat gastric mucosa,
and examined whether GW9662, an antagonist of PPAR-γ, can
attenuate the protective effects of pioglitazone and 15d-PGJ2 in
order to elucidate whether the protective effects of these ligands
are related to the activation of the PPAR-γ receptor. Finally, to
clarify the mechanism of cytoprotective properties of pioglitazone,
we performed a global analysis of gene expression in the gastric
mucosal cells of rats treated with pioglitazone.
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Materials and Methods
Reagents. All chemicals were prepared immediately before
use. Pioglitazone was donated from Takeda Pharmaceutical Co.,
Ltd. (Osaka, Japan). 15d-PGJ2 and GW9662 were obtained from
Cayman Chemical Co. (Ann Arbor, MI) and Sigma-Aldrich Japan
Inc. (Tokyo, Japan), respectively. PPAR-γ polyclonal antibody
(sc-6285) was purchased from Santa Cruz Biotech. (Santa Cruz,
CA). Isogen was purchased from Nippon Gene (Tokyo, Japan),
and Taq DNA polymerase was from Takara Shuzo Co. (Shiga,
Japan). Enzyme-linked immunosorbent assay (ELISA) kits for
TNF-α and CINC-1 were obtained from BioSource Int. (Camarillo,
CA) and Immuno-Biological Laboratories Co. (Gunma, Japan).
All other chemicals used were of reagent grade.
Preparation of rats for acute gastric mucosal injury
induced by ischemia reperfusion. Male Sprague-Dawley rats
weighing 190–210 g were obtained from Keari Co. Ltd. (Osaka,
Japan). They were housed in stainless steel cages with wire
bottoms and maintained on a 12-h light and 12-h dark cycle with
the temperature and relative humidity of the animal room
controlled at 21–23°C and 55–65%, respectively. They were not
fed for 18 h prior to the experiments, but were allowed free access
to water. Maintenance of animals and experimental procedures
were carried out in accordance with the US National Institutes
of Health Guidelines for the Use of Experimental Animals. All
experiments were approved by the Animal Care Committee of
Kyoto Prefectural University of Medicine (Kyoto, Japan). After
animals were given intraperitoneal urethane anesthesia (1000
mg/kg), gastric ischemia was induced by applying a small clamp
to the celiac artery for 30 min, followed by the removal of the
clamp for 60 min according to the previously reported method.(6)
Pioglitazone dissolved in 0.5% carboxymethyl cellulose (CMC)
and 15d-PGJ2 dissolved in physiological saline were given to the
rats by gastric intubation 1 h before the vascular clamping. To
evaluate the effect of agents on ischemia-reperfusion injury, mice
were divided into the following groups: 1) sham-operated mice
receiving 0.5% CMC solution, 2) I-R-treated mice receiving 0.5%
CMC solution, 3) sham-operated mice receiving pioglitazone
or 15d-PGJ2, and 4) I-R-treated mice receiving pioglitazone or
15d-PGJ2. A specific PPAR-γ antagonist GW9662 dissolved in
physiological saline was also given to rats intraperitoneally 2 h
before the vascular clamping.
Assessment of gastric mucosal injury induced by
ischemia reperfusion. To estimate the severity of the gastric
erosions induced by I-R, the total area of the red gastric lesions
that was measured using a dissecting microscope (×10 magnifica-
tion) with a square grid by a person blinded to the treatment. The
extent of any gastric mucosal lesions was expressed in terms of the
total area (mm2) of hemorrhagic erosions. Removed tissues were
fixed in 15% formaldehyde, embedded in paraffin, and sectioned
(5-μm slices), and the sections were stained with hematoxylin
eosin and viewed by an investigator blinded to the treatment.
Cell culture and preparation for anoxia reoxygenation.
The rat gastric mucosal cell line RGM-1 (RCB-0876 at Riken Cell
Bank, Tsukuba, Japan), established by Matsui and Ohno,(22) was
used for the present study. The RGM-1 cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco Labo-
ratories, Grand Island, NY) containing 10% fetal bovine serum
and antibiotics (100 U/ml penicillin, 100 μg/ml streptomycin, and
0.125 μg/ml amphotericin B). Cell cultures were incubated in
atmospheric air with 5% CO2 at 37°C. Confluent RGM-1 mono-
layers were exposed to hypoxia by incubation in Plexigas chamber
that was continuously purged (1 l/min) with an anoxic gas mixture
(95% N2 + 5% CO2), according to a method reported in a previous
study.(23,24) After a 120-min period of hypoxia, reoxygenation was
initiated by exposure the cells to atmospheric air with 5% CO2 at
37°C for 8 h. When we pretreated RGM-1 cells with pioglitazone,
we applied 1 and 10 μM pioglitazone dissolved in 0.5% dimethyl-
sulfoxide into the culture media for 60 min before anoxia treat-
ment.
Immunohistochemistry for PPAR γ. Expression and local-
ization of PPAR-γ in gastric tissue was detected by standard
immunohistochemical techniques using anti-PPAR-γ polyclonal
antibody on paraffin sections. The mAb were diluted in PBS
solutions containing 1% BSA and 0.1% Triton X-100 and applied
for overnight at 4°C. The sections were then incubated with
biotinylated anti-mouse IgG (Vectastatin Elite ABC kit, Vector
Laboratories) for 30 min. After they were washed, the specimens
were incubated with a mixture of avidin and horseradish peroxide-
conjugated biotin for 30 min and were reacted with 3,3'-diamino-
benzidine tetrahydrochloride at 0.2 mg/ml and 0.005% H2O2 in
Tris buffer. Nonimmune mouse IgG was used as a negative
control.
Reversed transcription polymerase chain reaction (RT 
PCR). For the evaluation of PPAR-γ, TNF-α and CINC-1 mRNA,
the gastric wall of rats was rinsed in PBS, snap-frozen in liquid
nitrogen, and then stored at −80°C until the time of RNA extrac-
tion. Total RNA was isolated from the gastric mucosal with the
acid guanidinium phenol chloroform method using an Isogen kit
(Nippon Gene, Tokyo, Japan). The concentration of RNA was
determined by absorbance at 260 nm in relation to absorbance
at 280 nm. RNA was stored at −70°C until reverse transcription
was performed. The RNA was used for reverse-transcription
polymerase chain reaction (RT-PCR) amplification. The amplifi-
cation was carried out in a 50 μl-mixture containing 2 μl of the RT
product, 0.6 μM of both the sense and antisense primers, 0.4 mM
dNTP mix, and 0.5 μl Taq DNA polymerase (Takara Shuzo Co.,
Shiga, Japan). The reaction was performed as follows: 35 cycles of
amplication (denaturation at 94°C for 30 s, annealing at 50°C for
30 s, and extension at 72°C for 60 s), followed by a final extension
step of 7 min at 72°C. Sequences for primers were: PPAR-γ
forward primer 5'-ATCGTGGGCCGCCCTAGGCA-3'; PPAR-γ
reverse primer 5'-TGGCCTTAGGGTTCAGAGGGG-3'; TNF-α,
forward primer 5'-ATGAGCACAGAAAGCATGATC-3'; TNF-α,
reverse primer 5'-TACAGGCTTGTCACTCGAATT-3'; CINC-1
forward primer sense 5'-CTGTGCTGGCCACCAGCCGC-3';
CINC-1 reverse primer 5'-ACAGTCCTTGGAACTTCTCTG-3';
and β-actin forward primer; 5'-ATCGTGGGCCGCCCTAGGCA-
3';  β-actin reversed primer 5'-TGGCCTTAGGGTTCAGAG
GGG-3'. The PCR reaction products were separated electrophoret-
ically in a 2.5% agarose gel and stained by ethidium bromide.
Quantitative real time PCR. After 2 h of administration with
vehicle solution or pioglitazone (10 mg/kg), total RNA was iso-
lated from the gastric mucosal with the acid guanidinium phenol
chloroform method using an Isogen kit (Nippon Gene). An aliquot
(1 μg) of extract RNA was reverse-transcribed into first-strand
complementary DNA (cDNA) at 42°C for 40 min, using 100 U/ml
reverse-transcriptase (Takara Biochemicals, Shiga, Japan) and
0.1 μM of oligo (dT)-adapter primer (Takara) in a 50 μL reaction
mixture. Real-time polymerase chain reaction (PCR) was carried
out with a 7300 Real Time PCR system (Applied Biosystems,
Foster City, CA) using the DNA-binding dye SYBER Green I
for the detection of PCR products according to the manufacturer’s
instructions. The reaction mixture (RT-PCR kit, Code RRO43A,
Takara) contained 12.5 μl Premix Ex Taq, 2.5 μl SYBER Green I,
custom-synthesized primers, ROX reference dye, cDNA (equiva-
lent to 20 ng total RNA) to give a final reaction volume of 25 μl.
Sequences for primers were: calnexin (CANX) forward primer
5'-TGCCATCTCTGCTAAACTGAACA-3'; CANX reverse primer
5'-CACCACCGCATT CTATTCCA-3'; endoplasmic reticulum
stress protein 72 (ERP70) forward primer 5'-ATGCTCTCCGAG
AATTTGTCATG-3'; ERP70 reverse primer 5'-CACCCTGACTG
GTCCCTTGT-3'; heat-shock 70 kD protein 5 (HSPA5) forward
primer 5'-CCATCACCAATGACCAAAACC-3'; HSPA5 reverse
primer 5'-GCGCTCTTTGAGCTTTTTGTC-3'; heat-shock protein
86 (HSPCA) forward primer 5'-CAGGCAGAAATTGCCCAGTT-doi: 10.3164/jcbn.10 81
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3';  HSPCA reverse primer 5'-AGAGCGTCTGAGGAGTTGG
AAA-3'; proteasome subunit beta type4 (PSMB4) forward primer
5'-GAAGCAAGTTCTCGGCCAGAT-3'; PSMB4 reverse primer
5'-ACATGGCCCTTGTCAACCA-3'; and β-actin forward primer
5'-GAGCAAACATCCCCCAAAGTT-3';  β-actin reverse primer
5'-GCCGTGGATACTTGGAGTGACT-3'. The PCR settings were
as follows: initial denaturation of 10 s at 95°C was followed by 40
cycle of amplification for 5 s at 95°C and 31 s at 60°C. Real-time
PCR was performed with universal cycling conditions (2 min at
50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C, and 1 min at
60°C). Data were analyzed using ABI Prism 7300 SDS Software
(Applied Biosystems). Standard curves relating initial template
copy number to fluorescence and amplification cycle were
generated using the amplified PCR product as a template, and
were used to calculate mRNA copy number in each sample. Ratios
of the intensities of the β-actin signals were used as a relative
measure of the expression level of each specimen.
Western blotting. The frozen tissue from rat stomach was
thawed on ice and homogenized at 4°C in a solution of 50 mmol/l
Tris-HCl, pH 7.6, 300 mmol/l NaCl, 0.5% Triton X-100, 10 mg/ml
aprotinin, 10 mg/ml leuptin, 1 mmol/l PMSF, 1.8 mg/ml iodoacet-
amide, 50 mmol/l NaF, and 1 mM DTT for extracting total cell
protein. Proteins were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
onto nitrocellulose (Bio-Rad Laboratories, Hercules, CA). Mem-
branes were probed with polyclonal antibody against PPAR-γ
(Santa Cruz Biotechnology Inc. Santa Cruz, CA). The immune
complexes were visualized by Western blotting with a commercial
kit (ECL by Amersham, BuckinghamshI-Re, England) according
to the manufacturer’s recommendations.
Measurements of TNF α and CINC 1. The concentrations of
inflammatory cytokines (TNF-α and CINC-1) in the supernatant of
mucosal homogenates and cell culture medium were determined by
rat TNF-α and CINC-1 specific enzyme-linked immunosorbent
assay (ELISA) kits according to the manufacturer’s instructions.
Laser capture microdissection, isolation of RNA, cDNA
synthesis, cRNA amplification, and GeneChip hybridiza 
tion. We used laser-assisted microdissection to obtain cell-
specific RNA. Gastric epithelial cells were identified on cryostat
sections (8 μm) of the specimens obtained from the stomach of the
rat, and the cells were isolated by laser-assisted microdissection
using an LM200 system (Olympus, Tokyo, Japan). A sample
containing several hundred cells was collected from each stomach.
According to the Affymetrix GeneChip Eukaryotic Small Sample
Target Labeling Assay protocol (Version II). Using this protocol,
we succeeded in obtaining a sufficient amount of biotinylated
cRNA to perform the GeneChip analysis from the small amount
of gastric epithelial cells obtained by laser captured micro-
dissection.(25) Labeled cRNA target was cleaned up using RNeasy
columns. The fragmentation, hybridization, washing, and staining
were carried out according to the instructions described in the
GeneChip Expression Analysis Technical Manual. Affymetrix
GeneChip arrays (Affymetrix, Santa Clara, CA) were hybridized
with the biotinylated products (5 μg/chip) for 16 h at 45°C using
the manufacturer’s hybridization buffer. After washing the arrays,
hybridized RNA was detected by staining with streptavidin-
phycoery-thrin. The DNA chips were scanned using a specially
designed confocal scanner (GeneChip Scanenr 3000, Affymetrix).
Statistics. Data of total area of erosions, contents of cytokines,
and real-time PCR analysis are expressed as mean (SEM). One-
way analysis of variance (ANOVA) with Scheffe’s multiple
comparison test was performed when more than two groups were
compared. Differences in mRNA expression determined by real-
time PCR between vehicle and pioglitazone treatments were
determined by Student’s t test. A p value of <0.05 was considered
statistically significant. All analyses were performed using Stat
View 5.0-J program (Abacus Concepts Inc. Berkeley, CA) on a
Macintosh computer.
Array data analysis was carried out using Affymetrix GeneChip
Operating Software (GCOS) version 1.0. GCOS analyzes image
data and computes an intensity value for each probe cell. Briefly,
mismatch probes act as specificity controls that allow the direct
subtraction of both background and cross-hybridization signals.
To determine the quantitative RNA abundance, the average differ-
ence values (i.e., gene expression levels) representing the perfect
match-mismatch for each gene-specific probe family is calculated,
and the fold changes in average difference values were determined
according to Affymetrix algorithms and procedures. For the
pathway analysis, gene probe set ID numbers were imported into
the Ingenuity Pathway Analysis software (Ingenuity Systems,
Mountain View, CA). The identified genes were mapped to
genetic networks available in the Ingenuity database and were
then ranked by a score. The score is the probability that a collec-
tion of genes is equal to or greater than the number in a network
that could be achieved by chance alone. A score of 3 indicates that
there is a 1/1000 chance (significance = 0.001) that the focus
genes are in a network randomly. Therefore, gene sets with scores
of 3 or higher have a 99.9% confidence of not being randomly
generated. This score was used as the cut-off for identifying gene
networks significantly affected by indomethacin.
Results
Expression of PPAR γ in rat gastric mucosa. To identify the
localization of PPAR-γ within stomach, we performed immuno-
histochemical analysis of PPAR-γ protein. As shown in Fig. 1a,
the expression of PPAR-γ was observed in mucosal epithelial
cells and parietal cells. Using cultured rat gastric mucosal cells
(RGM-1), the nuclear-dominant localization of PPAR-γ was
confirmed (Fig. 1 b and c), although the levels of PPAR-γ
expression in normal gastric mucosal cells was much lower
than those of gastric cancer cells. Western blotting also showed
the clear expression of PPAR-γ in the rat gastric mucosa (Fig. 1f),
and its levels were not changed by I-R but slightly increased by
the treatment with pioglitazone. RT-PCR also demonstrated the
PPAR-γ mRNA expression in the gastric mucosa (Fig. 1g). The
expression levels were slightly decreased after I-R.
Effect of PPAR γ ligands and antagonist on I R induced
gastric mucosal injury. According to our previous studies(14,18)
in which pre-treatment with pioglitazone or 15d-PGJ2 1 h before
the ischemia inhibited I-R-induced gastric mucosal injury in a
dose-dependent manner, we used pioglitazone at a dose of 10 mg/kg
and 15d-PGJ2 at a dose of 0.3 mg/kg and examined its pharmaco-
logical action in the present study. Neither ligand alone nor
GW9662, a PPAR-γ antagonist, alone produced any macroscopic
lesions in the rat stomach. I-R resulted in increase in total area of
erosions developed in the glandular stomach. Both pioglitazone
and 15d-PGJ2 significantly reduced the increase in total area of
erosions after I-R, and the protective effect of these ligands was
almost completely reversed by the co-administration with GW9662
(Fig. 2). The protective effect of pioglitazone and 15d-PGJ2 was
confirmed histologically (data not shown). I-R resulted in large
areas of epithelial crypt loss, predominantly neutrophilic infiltrate
throughout the mucosa and submucosa, erosion, and mucosal
bleeding. In contrast, pretreatment with pioglitazone or 15d-PGJ2
resulted in smaller erosions with few neutrophils.
Effects of pioglitazone on mucosal contents and mRNA
expression of TNF α and CINC 1 after I R, and on the CINC 1
production from stimulated gastric epithelial cells. To test if
pioglitazone treatment could modulate the inflammatory response
through regulation of cytokine production, we analyzed gastric
mucosal levels of TNF-α and CINC-1. The gastric concentrations
of TNF-α and CINC-1 increased significantly in rats treated I-R,
and these increases were significantly inhibited by treatment
with pioglitazone at a dose of 10 mg/kg (Fig. 3 a and b). To further
confirm the inhibitory effect of pioglitazone on TNF-α and J. Clin. Biochem. Nutr. | March 2011 | vol. 48 | no. 2 | 173
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CINC-1 production, we analyzed gastric expression of TNF-α
and CINC-1 using RT-PCR yielding 225 and 907 base pair
products to identify TNF-α and CINC-1 gene expression, respec-
tively. As shown in Fig. 3c, we found the expression of these
genes in the rat treated with sham-operation to be negligible or
faint. In contrast, transcription was readily shown in I-R-treated
rats. Treatment with pioglitazone suppressed mRNA expression
for each gene. In addition, pioglitazone markedly inhibited the
CINC-1 production from RGM-1 cells stimulated by 2 h-anoxia
and 6 h-reoxygenation (Fig. 3d).
Identification of genes differentially expressed in
pioglitazone treated gastric mucosa. We next asked what
genes are modulated following treatment of gastric mucosa with
pioglitazone and if there are differences between the affected gene
networks in pioglitazone-treated mucosa compared to non-treated
mucosa. Among the 1,032 probes (Rat Toxicology U34 array,
Affymetrix), the number of genes, the expression levels of which
increased or decreased more than 1.5-fold in pioglitazone-treated
Fig. 1. (a) Immunohistochemical staining for PPAR γ in stomach tissue of rats. (b–e) Nuclear localization of PPAR γ in RGM 1 cells (b, ×50, c, ×200, e,
negative control) and MKN45 cells (d, ×200). (f) Western blot detection of PPAR γ protein in homogenates of gastric mucosal tissues before and after
ischemia reperfusion (I R). (g) Expression of PPAR γ mRNA in the gastric mucosa determined by RT PCR. 1, sham operation, 2, ischemia reperfusion,
3, ischemia reperfusion + pioglitazone (10 mg/kg), 4, sham + pioglitazone.
Fig. 2. Effect of pioglitazone and 15 deoxy Δ12,14 prostaglandin J2 (15d PGJ2) on acute gastric mucosal injury induced by ischemia reperfusion (I R)
in rats. Multiple hemorrhagic erosions with acute edema developed in the glandular stomach of rats after 30 min ischemia and 60 min reperfusion,
and pioglitazone (10 mg/kg) and 15d PGJ2 (0.3 mg/kg) significantly inhibited the total area of gastric erosions induced by I R. GW9662 significantly
reversed the inhibition by these ligands against I R induced gastric injury. Data are expressed as mean (SEM) of 7 rats. #p<0.05 when compared to
control rats treated with I R, and +p<0.05 when compared to rats treated with I R plus pioglitazone or dimethyl PGJ2.doi: 10.3164/jcbn.10 81
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mucosa, was 35 including 10 ESTs. 18 probes were up-regulated
and 17 were down-regulated (Table 1). Table 2 showed a gene
network affected by pioglitazone, which obtained a most highest
score (score 14) as defined by the Pathway Analysis, and Fig. 4
demonstrated the associated network that was significantly
affected by pioglitazone. The shown network was significantly
associated with cell cycle, cell-to-cell signaling and interaction,
and cancer. This network included CANX, ERP70, heat-shock
protein 60 (HSP60), HSPA5, HSPCA, and PSMB4 genes.
Real time PCR for CANX, ERP70, HSP60, HSPA5, and
HSPCA genes. To confirm the data derived from GeneChip
analysis, we further validated the expression of some genes by
real-time quantitative PCR. As shown in Fig. 5, real time PCR
study showed that the expression of CANX, ERP70, HSPCA,
and PSMB4, but not HSPA5, was significantly increased by the
treatment with pioglitazone.
Discussion
In the present, we demonstrated the gastric expression of PPAR-
γ in rats by the immunohistochemistry and Western blotting using
a monoclonal antibody for PPAR-γ, and by mRNA expression for
PPAR-γ, and showed that GW9662, a PPAR-γ antagonist, reversed
the gastro-protective effects of pioglitazone and 15d-PGJ2 against
I-R injury. In addition, enhanced expression of proinflammatory
cytokines in the stomach after I-R was markedly inhibited by
pioglitazone. Finally, the global analysis of mRNA expression of
gastric mucosal cells obtained by the microdissection showed
that up- and down-regulated genes after the pioglitazone treat-
ment, and that anti-inflammatory effects of pioglitazone may be
associated with the up-regulation of HSPs and endoplasmic
reticulum-related proteins.
The most striking findings of the present study are that expres-
sion of PPAR-γ is observed in mainly gastric epithelial cells in
vivo and in cultured normal gastric epithelial cell line, which was
confirmed by immunohistochemistry, Western blot, and RT-PCR.
This is the first report in which the gastric PPAR-γ expression in
rats is confirmed. More interestingly, the expression of PPAR-γ
protein in the stomach was enhanced after the treatment of
pioglitazone without increased mRNA transcription, indicating
that pioglitazone may stabilize the protein of PPAR-γ. In contrast
to a previous report uisng renal cells by Matsuyama et al.,(26)
PPAR-γ expression was not enhanced after ischemia-reperfusion
in rats. Although the mechanism in regulating gastric mucosal
PPAR-γ expression is still unknown, the present data using DNA
microarray may give possible information about it.
In order to confirm whether the protective effect of PPAR-γ
ligands is due to activation of PPAR-γ, we have investigated
whether the PPAR-γ antagonist GW9662 attenuates the observed
protective effects of these ligands. We demonstrate here that
GW966 completely reversed the gastro-protective effects of
pioglitazone and 15d-PGJ2 against I-R injury. Recently, Wada
et al.(17) further defined the protective effects of endogenous
PPAR-γ activity in gastric injury induced by I-R through an
examination of PPAR-γ-deficient mice. They provided strong
evidence in support of an important role for endogenous PPAR-γ
activity in protecting from I-R injury in the stomach. Taken
together, these findings support the view that the activation of
PPAR-γ contributes to the protective and anti-inflammatory
effects of PPAR-γ ligands in rats subjected to gastric I-R.
The next meaningful finding of the present study is that
treatment with pioglitazone significantly inhibited I-R-driven
activation of proinflammatory cytokines (CINC-1 and TNF-α)
both in vivo (gastric mucosa) and in vitro (cultured gastric epithelial
cells). We demonstrated that, in I-R-induced gastric inflammation,
the expression of pro-inflammatory cytokines (CINC-1 and TNF-
Fig. 3. Effect of pioglitazone on CINC 1 contents (A), TNF α contents (B), the gastric expression of CINC 1/TNF α mRNA determined RT PCR (C), and
CINC 1 production from RGM 1 cells stimulated by anoxia reoxygenation (D). The concentration of CINC 1/TNF α in the supernatant of mucosal
homogenates was determined by ELISA kit specific for rat CINC 1 and rat TNF α. (A, B); Value reported as the mean ± SE of 6 to 8 rats. †p<0.01 when
compared to sham operated rats receiving 0.5% CMC solution (vehicle) alone, and #p<0.05 when compared to rats receiving vehicle plus ischemia 
reperfusion (I R). (C); A representative 2% agarose gel of RT PCR products for CINC 1 and TNF α mRNA is shown, also including β actin mRNA. (D);
†p<0.01 when compared to normoxia (N), and #p<0.05 when compared to anoxia reoxygenation (A/R). J. Clin. Biochem. Nutr. | March 2011 | vol. 48 | no. 2 | 175
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α) was enhanced in association with neutrophil accumulation,
as determined by myeloperoxidase activity in the homogenate of
the stomach.(27) These results suggest a transcriptional mechanism
by which PPAR-γ agonists may protect against gastric mucosal
injury via an inhibition of cytokine production.
Finally, to investigate cytoprotective action by pioglitazone
further, we compared the gene expression profiles between
vehicle- and pioglitazone-treated gastric mucosal cells. By the
pathway analysis, we demonstrated the associated network that
was significantly affected by pioglitazone. The shown network
was associated with cell cycle, cell-to-cell signaling and inter-
action, and cancer. This network includes CANX, ERP70, HSP60,
HSPA5, HSPCA, and PSMB4 genes, and the mRNA expression of
these genes were also confirmed by real-time PCR. In eukaryotic
cells, the endoplasmic reticulum (ER) plays an essential role in
the synthesis and maturation of a variety of important secretary
and membrane proteins. For glycoprotein, the ER possesses a
dedicated maturation system, which assists folding and ensures
the quality of final products before ER release. Essential compo-
nents of this system include the lectin chaperones CANX and
calreticulin (CRT) and their associated co-chaperone ERP, a
glycoprotein specific thiol-disulfide oxidoreductase.(28) These data
suggest that ER stress response induced by pioglitazone may be
associated with its anti-inflammatory or cytoprotective actions
on gastric mucosa. This hypothesis is supported by a recent report,
in which 15d-PGJ2 a PPAR-γ ligand, induced ER stress, and that
Table 1. Selected genes up  or down regulated by pioglitazone treatment in rats
Probe Set ID Description
Pioglitazone Normal Log 
Ratio
Fold 
difference Intensity Detection Intensity Detection
Up regulated
rc_AI236601_at strong similarity to mouse heat shock protein 105 kDa,
110 kDa protein
404.4 P 101.1 A 3.1 8.57
rc_AI176546_at heat shock protein 86 2691.4 P 724 P 2 4
K00996mRNA_s_at cytochrome P450, 2b19 1098.4 P 400 A 1.7 3.25
rc_AI010725_g_at calnexin 614.6 P 126.2 A 1.7 3.25
J05132_s_at UDP glycosyltransferase 1 family, polypeptide A6 8504.1 P 2629.8 P 1.4 2.64
M14050_s_at heat shock 70kD protein 5 853 P 374.2 P 1.4 2.64
rc_AI009141_at Transcribed sequences 315.8 P 141.9 A 1.4 2.64
rc_AI236795_s_at Rattus norvegicus heat[ ]shock protein 90 beta mRNA, 
partial sequence
6173.3 P 2105.4 P 1.4 2.64
L17127_g_at proteasome (prosome, macropain) subunit, beta type 4 772.1 P 286.7 P 1.3 2.46
rc_AI172452_at weak similarity to cytochrome c oxidase (EC 1.9.3.1) chain 
VIIa precursor   rat
1114.6 P 363.5 A 1.3 2.46
rc_AA859957_at moderate similarity to NADH dehydrogenase 1 beta 
subcomplex, 4
1152.9 P 706 A 1.2 2.3
rc_AI010725_at calnexin 686.4 P 356.8 P 1.1 2.14
M86870_at protein disulfide isomerase[ ]related protein 
(calcium binding protein)
465.7 P 239.4 P 0.8 1.74
X54793_at heat shock protein 60 (liver) 1504.5 P 816.4 P 0.8 1.74
Down regulated
rc_AA891651_g_at moderate similarity to NADH dehydrogenase acyl carrier 
chain, mitochondrial
348 A 705.1 P −0.8 0.57
rc_AA818226_s_at cytochrome c oxidase, subunit 4a 2388.7 P 5302.6 P −0.9 0.54
rc_AA900199_s_at Rattus norvegicus DD6C4 4 mRNA, partial sequence 345.5 M 695.8 P −0.9 0.54
rc_AA892041_at peroxiredoxin 6 411.5 A 849.8 P −1.2 0.44
rc_AI102505_g_at cytochrome c oxidase, subunit VIIIa 1560 P 3382.2 P −1.3 0.41
rc_AI177256_at Transcribed sequences 263.6 A 986.5 P −1.5 0.35
rc_AA963674_at eukaryotic translation elongation factor 2 1132.1 A 3972.2 P −1.6 0.33
Z78279_at collagen, type 1, alpha 1 146.9 A 327.3 M −1.7 0.31
rc_AA945054_s_at cytochrome b5 186.3 A 637.5 P −1.9 0.27
J05425cds_s_at cytochrome c oxidase, subunit 4a 218.9 A 1097.6 P −2.7 0.15
Table 2. Genetic networks up regulated by pioglitazone treatment analyzed by Pathway Analysis
Bold   Up[ ]regulated fo[c]us genes. Gene/Protein identified that made the user defined cutoff and map to the Global Molecular Network are
displayed with bold text. * Duplicates. Gene IDs marked with asterisks indicate that multiple identifiers from our input list mapped to a single gene
in the Global Molecular Network.
CANX, calnexin; ERP70, endoplasmic reticulum stress protein 72; HSP60, heat shock protein 60; HSPA5, heat shock 70 kD protein 5; HSPCA, heat shock
protein 86; PSMB4, proteasome subunit beta type4.
Network ID Genes in Network Score Focus Genes Top Function
1
APOB, BACE, CANX*, CDK4, ERP70, GAPD, HSP60, HSPA4, 
HSPA5, HSPCA, IGK@, MYC, PPP1CC, PSMA1, PSMA2, PSMA3, 
PSMA4, PSMA5, PSMA6, PSMA7, PSMB1, PSMB10, PSMB2, 
PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, 
SERPINA1, TRA@, TYR, TYRP1, VWF
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Fig. 4. A network of genes commonly regulated after pioglitazone treatment. Seven genes that were up regulated in pioglitazone treated
stomach were analyzed by the Ingenuity Pathway Analysis tool. The shown major network that was found to be significantly up regulated by
pioglitazone was associated with cell cycle, cell to cell signaling and interaction, and cancer. Shaded genes are the genes identified by microarray
analysis and others are those associated with the regulated genes based on the pathway analysis. The meaning of the node shapes is also indicated.
Asterisks indicate genes that were identified multiple times.
Fig. 5. Quantitative real time PCR for genes up regulated by pioglitazone treatment. cDNA was prepared from gastric mucosa, and PCR was
performed using an ABI 7300. The bars show levels of expression of each gene normalized to that of β actin. J. Clin. Biochem. Nutr. | March 2011 | vol. 48 | no. 2 | 177
©2011 JCBN
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ER stress activation was associated with an attenuation of cyto-
kine signaling in pancreatic β-cells.(29)
In summary, we confirmed the expression of PPAR-γ in the rat
gastric mucosa, and determined that the gastroprotective action of
PPAR-γ ligand was dependent on the activation of the PPAR-γ
receptor. Finally, we demonstrated that DNA microarray was a
highly effective way to generate a novel hypothesis on mechanism
of action of PPAR-γ ligand. In conclusion, activation of PPAR-γ
may represent a novel therapeutic approach for the therapy of
gastric inflammation.
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Abbreviations
CINC cytokine-induced neutrophil chemoattractant
CMC carboxymethyl cellulose
EMSA electrophoretic mobility shift assay
I-R ischemia-reperfusion
MPO myeloperoxidase
PPAR peroxisome proliferator-activated receptor
RT-PCR reverse-transcription polymerase chain reaction
TZD thiazolidinedione
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